SGX Pharmaceuticals, Inc. - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for SGX Pharmaceuticals, Inc.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

SGX Pharmaceuticals, Inc.. The Group's principal activety is to discover, develop & innovative cancer therapeutics. It develops Troxatyl, a novel compound which is currently in a pivotal Phase II/III clinical trial for the third-line treatment of Acute Myelogenous Leukemia, or AML, a blood cancer. Third-line treatment refers to the treatment of patients who have already received two regimens of chemotherapy with the goal of remission. it also developing an internal oncology product pipeline and lead compounds for multiple partners through the application of its proprietary fragment-based drug discovery platform, Fragments of Active Structures. It operates only in United States.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report